Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Arctic Bioscience AS ( (DE:9TD) ) has shared an announcement.
Arctic Bioscience is set to release its half-year results for 2025 on August 28, followed by a webcast presentation and Q&A session. This announcement is crucial for stakeholders as it provides insights into the company’s operational status and future prospects, potentially impacting its market positioning in the biotechnology industry.
More about Arctic Bioscience AS
Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical products and supplements based on unique bioactive marine raw materials. The company is working on HRO350, a new oral drug candidate for treating mild-to-moderate psoriasis. Their supplements are marketed globally under the brand ROMEGA®.
Average Trading Volume: 68,918
Current Market Cap: NOK111.5M
Find detailed analytics on 9TD stock on TipRanks’ Stock Analysis page.